7:39
Anifrolumab modulates key immune pathways in patients with systemic lupus erythematosus (SLE)
213 views • 1 month ago
4:34
CD7 activation regulates cytotoxicity-driven pathology in systemic sclerosis
551 views • 5 months ago
4:51
Bimekizumab treatment in patients with active axial spondyloarthritis: results up to week 52
144 views • 8 months ago
4:53
Bimekizumab 52-week efficacy and safety in biologic DMARD-naïve patients with active PsA
192 views • 9 months ago
6:52
EULAR recommendations for the non-pharmacological management of lupus and scleroderma
205 views • 10 months ago
4:55
Identification of two tofacitinib subpopulations with different relative risk versus TNF inhibitors
107 views • 1 year ago
5:31
Long-term persistence and effectiveness of IL-12/23 pathway inhibitor ustekinumab and TNF inhibitors
149 views • 1 year ago
4:34
Recapture and retreatment rates with ixekizumab after withdrawal of therapy in patients with axSpA
119 views • 1 year ago
4:01
ORAL Surveillance trial: risk of cardiovascular events with tofacitinib vs TNFi in patients with RA
618 views • 1 year ago
7:30
Olokizumab combined with methotrexate in patients with rheumatoid arthritis
280 views • 1 year ago
5:16
ROSAH syndrome is an autoinflammatory disease: Drs. Christina Kozycki and Dan Kastner, NIH
1.2K views • 1 year ago
6:24
Concordance and discordance in SLE clinical trial outcome measures
688 views • 2 years ago
6:41
Anifrolumab efficacy and safety by type I IFNGS and clinical subgroups in patients with SLE
550 views • 2 years ago
3:53
Meet the new Editor in Chief of ARD, Josef Smolen
236 views • 2 years ago
5:17
Persistence and effectiveness of the IL-12/23 pathway inhibitor ustekinumab
195 views • 2 years ago
5:01
Efficacy and safety of selective TYK2 inhibitor, deucravacitinib, trial in psoriatic arthritis
1.4K views • 2 years ago
4:16
Phase II Randomisedrandomised Trialtrial of Typetype I IIA
202 views • 2 years ago
4:11
Blocking GM-CSF receptor α with mavrilimumab reduces infiltrating cells
141 views • 2 years ago
5:14
Efficacy and safety of guselkumab in patients with active psoriatic arthritis
1.1K views • 2 years ago
2:36
Efficacy and safety results of a randomised controlled phase III study
169 views • 2 years ago
5:25
Secukinumab in patients with psoriatic arthritis and axial manifestations
1.5K views • 3 years ago
5:25
Revisiting the use of remission criteria for RA by excluding patient global assessment
255 views • 3 years ago
3:51
BBB leakage in SLE is associated with gray matter loss and cognitive impairment
382 views • 3 years ago
4:08
Infections in baricitinib clinical trials for patients with active rheumatoid arthritis
705 views • 3 years ago
3:28
Systemic evaluation of the relationship between psoriasis, psoriatic arthritis and osteoporosis
507 views • 3 years ago
4:39
Safety and tolerability of nintedanib in patients with interstitial lung disease
340 views • 3 years ago
2:32
Historically controlled comparison of glucocorticoids: results of the CHIC study
79 views • 3 years ago
3:34
Maintenance of Clinical Remission in Early Axial Spondyloarthritis
186 views • 4 years ago
4:14
Altered cognitive function in systemic lupus erythematosus
16K views • 4 years ago
6:23
Novel ultrasonographic Halo Score for giant cell arteritis
7.4K views • 4 years ago
Load More